Mirum Pharmaceuticals, Inc.
Develops and commercializes therapies for rare, debilitating liver diseases in children and adults.
MIRM | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6047491013
- LEI:
- Country:
- United States of America
- Address:
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, 94404 FOSTER CITY
- Website:
- https://mirumpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases affecting both children and adults. The company primarily focuses on debilitating liver diseases, including cholestatic conditions. Its pipeline includes LIVMARLI (maralixibat), an oral solution for the treatment of specific rare liver diseases. Mirum is committed to transforming scientific discoveries into treatments poised to change the trajectory of rare diseases for patients and their families.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Mirum Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mirum Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mirum Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
